Form 4: BioAge Labs COO Eric Morgen Acquires Stock Options
SEC Form 4 Filing
Eric Morgen, Chief Operating Officer of BioAge Labs, reports the acquisition of stock options.
Summary
- Eric Morgen, the Chief Operating Officer of BioAge Labs, filed a Form 4 detailing changes in beneficial ownership.
- The report includes the acquisition of 257,973 stock options at an exercise price of $8.39 on April 17, 2024.
- These options vest monthly, starting May 17, 2024, with the entire award exercisable at any time due to an early exercise feature.
- Morgen also indirectly owns 4,952 stock options through his spouse, vesting monthly starting October 1, 2024, at an exercise price of $18.
- Additionally, his spouse indirectly owns 13,598 stock options vesting monthly starting May 17, 2024, at an exercise price of $8.39.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock option grants. It suggests confidence from the executive but doesn't provide explicit positive or negative information about the company's performance.
Positives
- The acquisition of stock options by the COO could indicate confidence in the company's future performance.
Industry Context
Stock option grants are a common practice in the biotech industry to incentivize and retain key executives.
Comparison to Industry Standards
- Stock option grants are a typical component of executive compensation packages in the biotechnology industry.
- Comparing the size and vesting schedule of these options to similar companies like Amgen, Gilead Sciences, or Regeneron would provide context on whether these grants are standard or exceptional.
Stakeholder Impact
- The stock option grants could potentially align the COO's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/17/2024 | Date of transaction: Acquisition of stock options. |
| 05/17/2024 | First vesting date for 257,973 and 13,598 stock options. |
| 09/25/2024 | Date of stock option award. |
| 09/24/2034 | Expiration date for 4,952 stock options. |
| 10/01/2024 | First vesting date for 4,952 stock options. |
| 04/16/2034 | Expiration date for 257,973 and 13,598 stock options. |
| 09/27/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.